As of 2024-12-05, the EV/EBITDA ratio of Haemonetics Corp (HAE) is 16.38. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. HAE's latest enterprise value is 5,318.42 mil USD. HAE's TTM EBITDA according to its financial statements is 324.61 mil USD. Dividing these 2 quantities gives us the above HAE EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 10.7x - 17.5x | 13.8x |
| Forward P/E multiples | 16.7x - 24.4x | 21.0x |
| Fair Price | 50.47 - 123.20 | 87.38 |
| Upside | -42.3% - 40.9% | -0.1% |
| Date | EV/EBITDA |
| 2024-11-26 | 16.70 |
| 2024-11-25 | 16.54 |
| 2024-11-22 | 16.09 |
| 2024-11-21 | 16.07 |
| 2024-11-20 | 15.99 |
| 2024-11-19 | 15.98 |
| 2024-11-18 | 16.49 |
| 2024-11-15 | 16.65 |
| 2024-11-14 | 16.89 |
| 2024-11-13 | 17.05 |
| 2024-11-12 | 17.30 |
| 2024-11-11 | 16.99 |
| 2024-11-08 | 16.38 |
| 2024-11-07 | 16.24 |
| 2024-11-06 | 14.94 |
| 2024-11-05 | 14.45 |
| 2024-11-04 | 14.23 |
| 2024-11-01 | 13.91 |
| 2024-10-31 | 13.86 |
| 2024-10-30 | 13.99 |
| 2024-10-29 | 14.16 |
| 2024-10-28 | 14.57 |
| 2024-10-25 | 14.54 |
| 2024-10-24 | 14.58 |
| 2024-10-23 | 14.19 |
| 2024-10-22 | 14.37 |
| 2024-10-21 | 14.43 |
| 2024-10-18 | 14.63 |
| 2024-10-17 | 14.60 |
| 2024-10-16 | 14.54 |
| 2024-10-15 | 14.48 |
| 2024-10-14 | 14.50 |
| 2024-10-11 | 14.45 |
| 2024-10-10 | 14.37 |
| 2024-10-09 | 14.63 |
| 2024-10-08 | 14.71 |
| 2024-10-07 | 14.79 |
| 2024-10-04 | 14.90 |
| 2024-10-03 | 14.93 |
| 2024-10-02 | 15.12 |
| 2024-10-01 | 15.07 |
| 2024-09-30 | 15.29 |
| 2024-09-27 | 15.20 |
| 2024-09-26 | 14.69 |
| 2024-09-25 | 14.47 |
| 2024-09-24 | 14.53 |
| 2024-09-23 | 14.67 |
| 2024-09-20 | 14.43 |
| 2024-09-19 | 14.47 |
| 2024-09-18 | 14.55 |